House passes insulin bill over insurers’ opposition
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.
House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.
House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.
House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.
House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.
Attempts at price controls have to conform with the parameters of the reconciliation process they’re hoping to use to pass the social spending package on a party-line vote.
Attempts at price controls have to conform with the parameters of the reconciliation process they’re hoping to use to pass the social spending package on a party-line vote.
Attempts at price controls have to conform with the parameters of the reconciliation process they’re hoping to use to pass the social spending package on a party-line vote.
Attempts at price controls have to conform with the parameters of the reconciliation process they’re hoping to use to pass the social spending package on a party-line vote.
Industry-allied groups have spent $2.6 million on television advertisements opposing cuts to Medicare Advantage since the spring.
Industry-allied groups have spent $2.6 million on television advertisements opposing cuts to Medicare Advantage since the spring.
Industry-allied groups have spent $2.6 million on television advertisements opposing cuts to Medicare Advantage since the spring.
Industry-allied groups have spent $2.6 million on television advertisements opposing cuts to Medicare Advantage since the spring.
Industry-allied groups have spent $2.6 million on television advertisements opposing cuts to Medicare Advantage since the spring.
It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year.